Nancy D Chiaravalloti, Erica Weber, Silvana L Costa, Jean Lengenfelder, Diana Maloku, Nancy B Moore, John DeLuca
{"title":"Applying the Kessler Foundation Modified Story Memory Technique to Improve New Learning in Aging Populations.","authors":"Nancy D Chiaravalloti, Erica Weber, Silvana L Costa, Jean Lengenfelder, Diana Maloku, Nancy B Moore, John DeLuca","doi":"10.1159/000543682","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The current study examined the efficacy of the 10-session Kessler Foundation modified Story Memory Technique (KF-mSMT<sup>®</sup>) to improve new learning in older adults.</p><p><strong>Methods: </strong>This double-blind, placebo-controlled randomized clinical trial included twenty-eight individuals over age 65 randomized to the treatment group (<i>n</i> = 17) or placebo control group (<i>n</i> = 13). Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory, and a repeat assessment immediately post-treatment. The primary outcome measure was the total learning score from the California Verbal Learning Test II (CVLT-II) and the secondary outcome measure was the total score from the Memory Functioning Questionnaire.</p><p><strong>Results: </strong>A significant effect of the KF-mSMT<sup>®</sup> was noted on the CVLT-II total learning score in the treatment group, demonstrating a large effect size. Post hoc analysis examining benefit from the KF-mSMT<sup>®</sup> in the healthy aging group as compared with the mild cognitive impairment (MCI) group showed a trend toward significance (<i>p</i> = 0.069), with a large effect size. With benefit defined as a 10% or greater improvement in the CVLT total learning, 65% of patients in the treatment group showed improvement from baseline to immediate follow-up, compared with 31% of the control group (<i>p</i> = 0.06). Significant treatment effects were also noted in a self-report measure of memory in daily life, the Memory Functioning Questionnaire. Post-treatment changes in depression or anxiety from before to after treatment were not significant between the groups.</p><p><strong>Conclusion: </strong>The current study presents preliminary evidence in support of the KF-mSMT<sup>®</sup> for improving learning and memory abilities in older populations of those aging normally and those meeting criteria for MCI.</p>","PeriodicalId":38017,"journal":{"name":"Dementia and Geriatric Cognitive Disorders Extra","volume":"15 1","pages":"37-46"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11908804/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and Geriatric Cognitive Disorders Extra","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000543682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The current study examined the efficacy of the 10-session Kessler Foundation modified Story Memory Technique (KF-mSMT®) to improve new learning in older adults.
Methods: This double-blind, placebo-controlled randomized clinical trial included twenty-eight individuals over age 65 randomized to the treatment group (n = 17) or placebo control group (n = 13). Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory, and a repeat assessment immediately post-treatment. The primary outcome measure was the total learning score from the California Verbal Learning Test II (CVLT-II) and the secondary outcome measure was the total score from the Memory Functioning Questionnaire.
Results: A significant effect of the KF-mSMT® was noted on the CVLT-II total learning score in the treatment group, demonstrating a large effect size. Post hoc analysis examining benefit from the KF-mSMT® in the healthy aging group as compared with the mild cognitive impairment (MCI) group showed a trend toward significance (p = 0.069), with a large effect size. With benefit defined as a 10% or greater improvement in the CVLT total learning, 65% of patients in the treatment group showed improvement from baseline to immediate follow-up, compared with 31% of the control group (p = 0.06). Significant treatment effects were also noted in a self-report measure of memory in daily life, the Memory Functioning Questionnaire. Post-treatment changes in depression or anxiety from before to after treatment were not significant between the groups.
Conclusion: The current study presents preliminary evidence in support of the KF-mSMT® for improving learning and memory abilities in older populations of those aging normally and those meeting criteria for MCI.
期刊介绍:
This open access and online-only journal publishes original articles covering the entire spectrum of cognitive dysfunction such as Alzheimer’s and Parkinson’s disease, Huntington’s chorea and other neurodegenerative diseases. The journal draws from diverse related research disciplines such as psychogeriatrics, neuropsychology, clinical neurology, morphology, physiology, genetic molecular biology, pathology, biochemistry, immunology, pharmacology and pharmaceutics. Strong emphasis is placed on the publication of research findings from animal studies which are complemented by clinical and therapeutic experience to give an overall appreciation of the field. Dementia and Geriatric Cognitive Disorders Extra provides additional contents based on reviewed and accepted submissions to the main journal Dementia and Geriatric Cognitive Disorders Extra .